Goods & Services

Antimicrobial nasal sprays and rinses, antimicrobial throat gargles, sprays and washes, antimicrobial sprays and rinses for administration to the ear, antimicrobial body washes and soaps, antimicrobial skin cleansers, antimicrobial sprays and rinses for topical use, topical formulations containing povidone iodine.

Goods & Services

Sanitary preparations being non-medicated toiletry preparations; unmedicated nasal cleaning preparations for personal sanitary purposes

Abstract

The present invention is directed to PVP-I formulations having enhanced virucidal activity. The formulations are intended for topical administration for treatment and/or decreased risk of microbial infections in subjects. The formulations include PVP-I and other ingredients selected to enhance the virucidal activity of the formulation over PVP-I alone.

IPC Classes  ?

• A61K 33/18 - IodineCompounds thereof
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/32 - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
• A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses
• A61P 31/14 - Antivirals for RNA viruses

Abstract

This invention is directed to methods for prevention of infections by highly pathogenic viruses by applying to the nasal mucous membranes topical preparations comprising the broad-spectrum antimicrobial agent povidone-iodine.

IPC Classes  ?

• A61K 31/79 - Polymers of vinyl pyrrolidone
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/08 - Solutions
• A61K 9/127 - Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
• A61K 33/18 - IodineCompounds thereof
• A61K 47/32 - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
• A61P 31/04 - Antibacterial agents
• A61P 31/12 - Antivirals
• A61P 31/14 - Antivirals for RNA viruses
• A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses

Goods & Services

Pharmaceutical preparations; anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; pharmaceutical preparations for health care; pharmaceutical preparations for human use; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for personal use; pharmaceutical preparations for topical use; pharmaceutical products; pharmaceutical products for use by humans; preparations for application to the body (pharmaceuticals); pharmaceutical preparations in nasal spray form; pharmaceutical preparations for the skin, nails, scalp and body.

Goods & Services

(1) Pharmaceutical preparations for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals; Pharmaceutical preparations for the treatment and prevention of dandruff; Pharmaceutical preparations for the treatment and prevention of bacteria that causes body odour; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of skin diseases, namely, diaper rash, heat rashes, hemorrhoids, chafed skin, minor burns, bed sores, abrasions, shingles, chapped lips, incontinent rashes, poison ivy and oak, rectal itching and fever blisters; Pharmaceutical preparations for the treatment and prevention of nail fungus; anti-bacterial pharmaceutical preparations namely antibacterials, antibacterial spray; iodine for pharmaceutical purposes; pharmaceutical preparations for health care for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for health care; pharmaceutical preparations for human use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for human use; pharmaceutical preparations for nasal use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for nasal use; pharmaceutical preparations for oral use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for oral use; pharmaceutical preparations for personal use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for personal use; pharmaceutical preparations for topical use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for topical use; pharmaceutical products for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals; pharmaceutical products for use by humans for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for use by humans; pharmaceutical preparations for application to the body for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for topical use; pharmaceutical preparations in nasal spray form for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals in nasal spray form; pharmaceutical preparations for the skin, nails, scalp and body for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for the skin, nails, scalp, and body.

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bacterial and viral infections and diseases; Pharmaceutical preparations for the treatment and prevention of dandruff; Pharmaceutical preparations for the treatment and prevention of bacteria that causes body odour; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of skin diseases; Pharmaceutical preparations for the treatment and prevention of nail fungus; anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; pharmaceutical preparations for health care for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for human use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for nasal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for oral use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for personal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for topical use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for use by humans for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for application to the body for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations in nasal spray form for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for the skin, nails, scalp and body for the treatment and prevention of bacterial and viral infections and diseases

Abstract

The present invention is directed to PVP-I formulations having enhanced virucidal activity. The formulations are intended for topical administration for treatment and/or decreased risk of microbial infections in subjects. The formulations include PVP-I and other ingredients selected to enhance the virucidal activity of the formulation over PVP-I alone.

IPC Classes  ?

• A61K 33/18 - IodineCompounds thereof
• A61K 31/79 - Polymers of vinyl pyrrolidone
• A61K 31/045 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates
• A61P 31/04 - Antibacterial agents
• A61P 31/12 - Antivirals
• A61P 31/14 - Antivirals for RNA viruses
• A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses

Goods & Services

Iodine for pharmaceutical purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; topical pharmaceutical preparations; nail fungus treatment preparations; antibacterial pharmaceutical preparations; antiseptic preparations.

Goods & Services

(1) Iodine for pharmaceutical purposes; pharmaceutical preparations for skin care namely medicated skin care preparations for treating body odor; pharmaceutical preparations for treating dandruff; medicated topical skin preparations containing iodine; pharmaceutical preparations for skin care containing iodine; nail fungus treatment preparations; antibacterials; antiseptic preparations

Goods & Services

Iodine for pharmaceutical purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; topical pharmaceutical preparations for the treatment of and elimination of bacteria that causes body odour; nail fungus treatment preparations; antibacterial pharmaceutical preparations; antiseptic preparations

Abstract

This invention is directed to methods for prevention of infections by highly pathogenic viruses by applying to the nasal mucous membranes topical preparations comprising the broad-spectrum antimicrobial agent povidone-iodine.

IPC Classes  ?

• A61K 31/79 - Polymers of vinyl pyrrolidone
• A61P 31/12 - Antivirals
• A61P 31/14 - Antivirals for RNA viruses
• A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses
• A61P 31/04 - Antibacterial agents
• A61K 33/18 - IodineCompounds thereof
• A61K 47/32 - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/08 - Solutions
• A61K 9/127 - Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Goods & Services

Anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; pharmaceutical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for human use; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for personal use; pharmaceutical preparations for topical use; pharmaceutical products; pharmaceutical products for use by humans; preparations for application to the body (pharmaceuticals).

Goods & Services

Pharmaceutical preparations for nasal use; pharmaceutical preparations for the treatment and prevention of infections of the nose and throat; pharmaceutical preparations for the treatment and prevention of viral infections

Goods & Services

(1) Anti-bacterial pharmaceutical preparations namely antibacterials, antibacterial spray; iodine for pharmaceutical purposes; pharmaceutical preparations namely anti-viral agents, pharmaceutical preparations for the treatment of infectious diseases namely respiratory infections, pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections, pharmaceutical preparations for the treatment of viral diseases namely influenza, rhinovirus, pneumonia and the common cold, pharmaceutical preparations for the treatment of viral infections namely influenza, rhinovirus, pneumonia and the common cold, pharmaceuticals for the treatment of coronavirus diseases and COVID-19

Goods & Services

Anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; iodine for medical purposes; medical preparations; medicated antiseptic preparations for application to the skin; pharmaceutical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for human use; pharmaceutical preparations for personal use; pharmaceutical preparations for topical use; pharmaceutical products; pharmaceutical products for use by humans; preparations for application to the body (pharmaceuticals); preparations for combating attack by microbial pests; sprays (preparations) for the body (for medical use); sprays for use on the body (pharmaceuticals); nasal washes.

Goods & Services

Anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; pharmaceutical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for human use; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for personal use; pharmaceutical preparations for topical use; pharmaceutical products; pharmaceutical products for use by humans; preparations for application to the body (pharmaceuticals).

Abstract

The present invention provides a method of treating and preventing the common cold and associated secondary illnesses in a human subject, when the common cold is caused by viruses. The method comprises applying to the nasal passages of the human subject at ambient temperature, an effective amount of a pharmaceutical preparation comprising povidone-iodine (PVP-I) at a concentration of greater than 0.10% w/v and less than 2.5% in which at least 50% of the PVP-I is not associated with liposomes or other particulate carriers.

IPC Classes  ?

• A61K 33/18 - IodineCompounds thereof
• A61K 31/79 - Polymers of vinyl pyrrolidone
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses
• A61P 31/14 - Antivirals for RNA viruses
• A61P 31/12 - Antivirals
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca